DRP Journal

Discover Research Profit

Finance 

Therapeutic Solutions International (OTCMKTS:TSOI) Stock Continues To Trend Higher: But Why?

Pete Matthews , , , ,

Therapeutic Solutions International (OTCMKTS:TSOI) on April 20, 2023, announced the filing of a new Phase III clinical trial application with the FDA. The application entails the use of JadiCell adult stem cells to treat acute respiratory distress syndrome. The investigational drug application is based on the firm’s existing data as well as experiences related to Phase III clinical trials in COVID-19-associated ARDS.

Trading Data

On Thursday, TSOI stock soared 7.69% to $0.0042 with 80.58 million shares, compared to its average volume 9.33 million shares. The stock moved within a range of $0.0039 – 0.0063 after opening trade at $0.0039.

Therapeutic Solutions International Files to Initiate Phase III Clinical Trial for Acute Respiratory Distress Syndrome (ARDS) Leveraging Positive COVID-19 Data with JadiCell Stem Cell Therapy

ARDS is a condition that witnesses lung injury causing fluid to leak between the capillaries and the alveoli. This leads to several cascading problems, reducing the lungs’ capacity to carry oxygen in the blood. ARDS impacts about 190,000 Americans a year and may reach 19.5 billion dollars a year market by 2029.

The company’s decision is to fasten the development of ARDS programs from a published decision by the U.S. Patent Trial and Appeal Board. This patent is exclusive to Therapeutic Solutions International and covers the composition of matter of the JadiCells. It has been published to be 100% effective for patients under 85 years of age in COVID-19-induced ARDS patients.

Dr. James Veltmeyer, Principle Investigator of the Study said that the firm has maintained a steady course in achieving milestone of in-licensing an advanced cell therapeutic product. Veltmeyer added that it is demonstrating different clinical situation advantages and has initiated steps in product development.

Pete Matthews

Pete attended the University of Colorado and still calls the centennial state home. He chases trout in the summer and snowboards in the winter. He is fascinated with the markets and has a strong interest in nanocap stocks and crypto currency.